» Articles » PMID: 36982693

Dopamine Transmission Imbalance in Neuroinflammation: Perspectives on Long-Term COVID-19

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 Mar 29
PMID 36982693
Authors
Affiliations
Soon will be listed here.
Abstract

Dopamine (DA) is a key neurotransmitter in the basal ganglia, implicated in the control of movement and motivation. Alteration of DA levels is central in Parkinson's disease (PD), a common neurodegenerative disorder characterized by motor and non-motor manifestations and deposition of alpha-synuclein (α-syn) aggregates. Previous studies have hypothesized a link between PD and viral infections. Indeed, different cases of parkinsonism have been reported following COVID-19. However, whether SARS-CoV-2 may trigger a neurodegenerative process is still a matter of debate. Interestingly, evidence of brain inflammation has been described in postmortem samples of patients infected by SARS-CoV-2, which suggests immune-mediated mechanisms triggering the neurological sequelae. In this review, we discuss the role of proinflammatory molecules such as cytokines, chemokines, and oxygen reactive species in modulating DA homeostasis. Moreover, we review the existing literature on the possible mechanistic interplay between SARS-CoV-2-mediated neuroinflammation and nigrostriatal DAergic impairment, and the cross-talk with aberrant α-syn metabolism.

Citing Articles

Alterations in Striatal Architecture and Biochemical Markers' Levels During Postnatal Development in the Rat Model of an Attention Deficit/Hyperactivity Disorder (ADHD).

Bogdanska-Chomczyk E, Wojtacha P, Tsai M, Huang A, Kozlowska A Int J Mol Sci. 2025; 25(24.

PMID: 39769412 PMC: 11680085. DOI: 10.3390/ijms252413652.


Prevalence and associated risk factors of post COVID fatigue among Parkinson's disease patients during one year follow up.

Yang C, Guo D, Zhu Y, Tian M, Zhang B, Yang Y Sci Rep. 2024; 14(1):31966.

PMID: 39738701 PMC: 11685509. DOI: 10.1038/s41598-024-83567-1.


Olfactory Epithelium Infection by SARS-CoV-2: Possible Neuroinflammatory Consequences of COVID-19.

Gutierrez-Garcia A, Contreras C Complex Psychiatry. 2024; 10(1-4):59-70.

PMID: 39545135 PMC: 11560153. DOI: 10.1159/000540982.


Neurological, psychological, psychosocial complications of long-COVID and their management.

Narayanan S, Padiyath S, Chandrababu K, Raj L, P S B, Ninan G Neurol Sci. 2024; 46(1):1-23.

PMID: 39516425 PMC: 11698801. DOI: 10.1007/s10072-024-07854-5.


Long Neuro-COVID-19: Current Mechanistic Views and Therapeutic Perspectives.

Slama Schwok A, Henri J Biomolecules. 2024; 14(9).

PMID: 39334847 PMC: 11429791. DOI: 10.3390/biom14091081.


References
1.
Felger J, Alagbe O, Hu F, Mook D, Freeman A, Sanchez M . Effects of interferon-alpha on rhesus monkeys: a nonhuman primate model of cytokine-induced depression. Biol Psychiatry. 2007; 62(11):1324-33. PMC: 2149847. DOI: 10.1016/j.biopsych.2007.05.026. View

2.
Gao N, Li Y, Li X, Yu S, Fu G, Chen B . Effect of alpha-synuclein on the promoter activity of tyrosine hydroxylase gene. Neurosci Bull. 2007; 23(1):53-7. PMC: 5550569. DOI: 10.1007/s12264-007-0008-z. View

3.
Capuron L, Dantzer R . Cytokines and depression: the need for a new paradigm. Brain Behav Immun. 2003; 17 Suppl 1:S119-24. DOI: 10.1016/s0889-1591(02)00078-8. View

4.
Cohen M, Eichel R, Steiner-Birmanns B, Janah A, Ioshpa M, Bar-Shalom R . A case of probable Parkinson's disease after SARS-CoV-2 infection. Lancet Neurol. 2020; 19(10):804-805. PMC: 7494295. DOI: 10.1016/S1474-4422(20)30305-7. View

5.
MohanKumar P, ThyagaRajan S, Quadri S . Interleukin-1 stimulates the release of dopamine and dihydroxyphenylacetic acid from the hypothalamus in vivo. Life Sci. 1991; 48(9):925-30. DOI: 10.1016/0024-3205(91)90040-i. View